Abstract
The main area of abuse is in bodybuilding and sports. Because androgens have other actions on the body, one particular systemic action has been exploited to good and bad use, i.e., its maintenance of muscle strength and mass (Melton 2000). This benefit to health and QOL is useful to prevent frailty of aging but is often abused in competitive sports.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Bibliography
Achar S, Rostamian A, Narayan SM. Cardiac and metabolic effects of anabolic-androgenic steroid abuse on lipids, blood pressure, left ventricular dimensions, and rhythm. Am J Cardiol. 2010;106(6):893–901.
Arnold AM, Peralta JM, Thonney ML. Ontogeny of growth hormone, insulin-like growth factor-I, estradiol and cortisol in the growing lamb: effect of testosterone. J Endocrinol. 1996;150(3):391–9.
Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter Jr AM, et al. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail. 2010;3(4):472–6.
Bahrke MS, Yesalis 3rd CE, Wright JE. Psychological and behavioural effects of endogenous testosterone levels and anabolic-androgenic steroids among males. A review. Sports Med. 1990;10(5):303–37.
Basaria S. Androgen abuse in athletes: detection and consequences. J Clin Endocrinol Metab. 2010;95(4):1533–43.
Basaria S, Wahlstrom JT, Dobs AS. Clinical review 138: anabolic-androgenic steroid therapy in the treatment of chronic diseases. J Clin Endocrinol Metab. 2001;86(11):5108–17.
Berger JR, Pall L, Hall CD, et al. Oxandrolone in AIDS-wasting myopathy. AIDS. 1996;10(14):1657–62.
Berkow R, editor. The Merck manual of diagnosis and therapy. 15th ed. Rahway: Merck Sharp and Dohme Research Laboratories; 1987. p. 1208.
Birgner C, Kindlundh-Högberg AM, Alsiö J, et al. The anabolic androgenic steroid nandrolone decanoate affects mRNA expression of dopaminergic but not serotonergic receptors. Brain Res. 2008;1240:221–8.
Bucher G, Berger DS, Fields-Gardner C, et al. A prospective study on the safety and effect of nandrolone decanoate in HIV positive patients. In: Abstract of the 11th Conference on AIDS, Vancouver, 1996.
Danhaive PA, Rousseau GG. Binding of glucocorticoid antagonists to androgen and glucocorticoid hormone receptors in rat skeletal muscle. J Steroid Biochem. 1986;24(2):481–7.
Demling R, De Santi L. Closure of the “non-healing wound” corresponds with correction of weight loss using the anabolic agent oxandrolone. Ostomy Wound Manage. 1998;44(10):58–62, 64, 66 passim.
Di Paolo M, Agozzino M, Toni C, et al. Sudden anabolic steroid abuse-related death in athletes. Int J Cardiol. 2007;114(1):114–7. Epub 2005 Dec 20.
Di Pasquale MG. Drug Use and detection in amateur sports. Warkworth: MGD Press; 1984.
Dimick DF, Heron M, Baulieu EE, et al. A comparative study of the metabolic fate of testosterone, 17 alpha-methyl-testosterone. 19-nor-testosterone. 17 alpha-methyl-19-nor-testosterone and 17 alpha-methylestr-5(10)-ene-17 beta-ol-3-one in normal males. Clin Chim Acta. 1961;6:63–71.
Falanga V, Greenberg AS, Zhou L, et al. Stimulation of collagen synthesis by the anabolic steroid stanozolol. J Invest Dermatol. 1998;111(6):1193–7.
Ferreira IM, Verreschi IT, Nery LE, et al. The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest. 1998;114(1):19–28.
Fineschi V, Riezzo I, Centini F, et al. Sudden cardiac death during anabolic steroid abuse: morphologic and toxicologic findings in two fatal cases of bodybuilders. Int J Legal Med. 2007;121(1):48–53. Epub 2005 Nov 15.
Gaughan WJ, Liss KA, Dunn SR, et al. A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Am J Kidney Dis. 1997;30(4):495–500.
Gaul, Morato, Hayano, et al. Biosynthesis of estrogens. Endocrinol. 1962;71.
Gold J, High HA, Li Y, et al. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection. AIDS. 1996;10(7):745–52.
Graham MR, Evans P, Davies B, Baker JS. AAS, growth hormone, and insulin abuse: psychological and neuroendocrine effects. Ther Clin Risk Manag. 2008;4(3):587–97.
Johansen KL, Mulligan K, Schambelan M. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA. 1999;281(14):1275–81.
Kokkevi A, Fotiou A, Chileva A, et al. Daily exercise and anabolic steroids use in adolescents: a cross-national European study. Subst Use Misuse. 2008;43(14):2053–65.
Lau DH, Stiles MK, John B, et al. Atrial fibrillation and anabolic steroid abuse. Int J Cardiol. 2007;117(2):e86–7.
Mendenhall CL, Moritz TE, Roselle GA, et al. A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis: results of a Department of Veterans Affairs cooperative study. Hepatology. 1993;17(4):564–76.
Phillis BD, Abeywardena MY, Adams MJ, et al. Nandrolone potentiates arrhythmogenic effects of cardiac ischemia in the rat. Toxicol Sci. 2007;99(2):605–11. Epub 2007 Jul 25.
Rada RT, Kellner R, Winslow WW. Plasma testosterone and aggressive behavior. Psychosomatics. 1976;17(3):138–42.
Rosenfeld RL. Role of androgens in growth and development of the fetus, child, and adolescent. Adv Pediatr. 1972;19:171–213.
Samuels LT, Sellers DM, McCaulay CJ. The source of excess creatine following methyl testosterone. J Clin Endocrinol Metab. 1946;6(10):655–63.
Schols AM, Soeters PB, Mostert R, et al. Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med. 1995;152(4 Pt 1):1268–74.
Schwingel PA, Cotrim HP, Salles BR, Almeida CE, dos Santos Jr CR, Nachef B, et al. Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease. Liver Int. 2011;31(3):348–53.
Snyder PJ, Peachey H, Hannoush P, et al. Effect of testosterone treatment on bone mineral density in men over 65 years of age. J Clin Endocrinol Metab. 1999;84(6):1966–72.
Spungen AM, Grimm DR, Strakhan M, et al. Treatment with an anabolic agent is associated with improvement in respiratory function in persons with tetraplegia: a pilot study. Mt Sinai J Med. 1999;66(3):201–5.
Steele RE, Didato F, Steinetz BG. Relative importance of 5alpha reduction for the androgenic and LH-inhibiting activities of delta-4-3-ketosteroids. Steroids. 1977;29(3):331–48.
Strawford A, Barbieri T, Van Loan M, et al. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA. 1999;281(14):1282–90.
Talih F, Fattal O, Malone Jr D. Anabolic steroid abuse: psychiatric and physical costs. Cleve Clin J Med. 2007;74(5):341–4, 346, 349–52.
Urban RJ, Bodenburg YH, Gilkison C, et al. Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 1995;269(5 Pt 1):E820–6.
Vogel W, Klaiber EL, Broverman DM. A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men. J Clin Psychiatry. 1985;46(1):6–8.
Wilson IC, Prange Jr AJ, Lara PP. Methyltestosterone with imipramine in men: conversion of depression to paranoid reaction. Am J Psychiatry. 1974;131(1):21–4.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Lim, P.H.C. (2013). Effects of Excessive Androgen Use and Abuse. In: Lim, P. (eds) Men's Health. Springer, London. https://doi.org/10.1007/978-1-4471-4766-4_12
Download citation
DOI: https://doi.org/10.1007/978-1-4471-4766-4_12
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-4765-7
Online ISBN: 978-1-4471-4766-4
eBook Packages: MedicineMedicine (R0)